Current Trials

Page 1 to 3 of 18 active clinical trial pages. Go to   FIRST | PREVIOUS | NEXT | LAST

Very Important:  Each study includes additional requirements concerning the privacy of every individual or particular study and are not detailed here. If you believe you meet any of the basic requirements for any of the studies listed, please call (305) 885-8983 or Join a study registering as a volunteer. Know that if you do not qualify for this study, maybe qualify for another clinical trial. Finally, we want to emphasize that you must first pass a rigorous medical exam before being elected as a volunteer, and meet other requirements specific to each clinical study, no publicly exposed here.

Hyperlipidemia
High Cholesterol

What is hyperlipidemia?

Quick Description:  Lipid is the scientific term for fats in the blood. At proper levels, lipids perform important functions in your body, but can cause health problems if they are present in excess. The term hyperlipidemia means high lipid levels. Hyperlipidemia includes several conditions, but it usually means that you have high cholesterol and high triglyceride levels.

Main Inclusion Criteria:

  • Must be 18 year of age or older with confirmed prior CVD event
  • Men aged 55 or older, or Women aged 65 or older with a CVD risk equivalent

Posted on: 2014-08-21 14:41:01

Join to this study now!

Opioid Induced Constipation
(OIC)

What are opioids?

Quick Description:  Opioids are a class of drugs that are commonly prescribed for their analgesic, or pain-killing, properties.

Main Inclusion Criteria:

  • Participants must be between 18 to 80 years old inclusive at the time of informed consent
  • Subjects must have non-malignant chronic pain treated with opioids for at least 3 months and must have OIC

Posted on: 2014-08-21 14:45:11

Join to this study now!

Diabetes & Chronic Kidney Disease
Diabetes (Type 2)

Quick Description:  N/A please, Contact Us

Main Inclusion Criteria:

  • Male or female, 18 years of age or older
  • Female subjects who are of non-child bearing potential
  • Clinical diagnosis of Type 2 Diabetes
  • Documented history of persistent, overt albuminuria; defined as a UACR, less than or equal to, 300 mg/g or equivalent, for 3 months or longer
  • Stable background therapy of RAAS inhibition for at least 3 months before screening
  • Be able to be maintained for the duration of the study

Posted on: 2014-08-21 14:47:13

Join to this study now!

Studies 1 to 3 of 18 records. Go to   FIRST | PREVIOUS | NEXT | LAST

Last update: 02/9/2021 04:05
Content updated on Tuesday, 02-9-2021 05:30:52 pm